Should Fixing Xarelto Lawsuit Take 60 Steps
Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical firms, including the makers of Xarelto, possess a duty to make next34.sakura.ne.jp sure that their drugs are reasonably protected for use - and failure to perform so could be grounds for compensation. Our lawyers are working difficult to obtain those hurt by the drug the compensation they are entitled to.
Even though bleeding can be a widespread complication linked with anticoagulants, it has been alleged that Xarelto is far more hazardous than conventional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This indicates that, inside the occasion of an emergency, sufferers may possibly be at danger for irreversible bleeding difficulties, like life-threatening internal and gastrointestinal hemorrhaging.
If you or a loved a single suffered a significant bleeding event soon after taking Xarelto, you might have legal recourse. For much more information, speak to us nowadays to possess your case reviewed, free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for past and future health-related bills, lost wages, discomfort and suffering and, in situations of death, funeral expenditures. In addition, they are in search of punitive damages, which are normally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Becoming Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is dangerous and defective. The plaintiffs claim that, unlike standard anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective implies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs inside the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a safe anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.
Visit this page for more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
